← FDA Drug Approvals (Drugs@FDA)

ANDA217456

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SABA ILAC SANAYIVE · Approved 2024-06-13

Drug application

FDA Application #

ANDA217456

Application type

Abbreviated New Drug Application (Generic)

Brand name

—

Generic name

—

Active ingredients

—

Dosage form

—

Route

—

Marketing status

—

Sponsor

SABA ILAC SANAYIVE

First approval

2024-06-13

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown